Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.
2.

Hyaluronan in canine arthropathies.

Arican M, Carter SD, May C, Bennett D.

J Comp Pathol. 1994 Aug;111(2):185-95.

PMID:
7806704
4.
5.
6.

Measurement of glycosaminoglycans and keratan sulphate in canine arthropathies.

Arican M, Carter SD, Bennett D, May C.

Res Vet Sci. 1994 May;56(3):290-7.

PMID:
8073179
7.

Evaluation of a collagenase generated osteoarthritis biomarker in naturally occurring canine cruciate disease.

Hayashi K, Kim SY, Lansdowne JL, Kapatkin A, Déjardin LM.

Vet Surg. 2009 Jan;38(1):117-21. doi: 10.1111/j.1532-950X.2008.00446.x.

PMID:
19152626
8.

Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and synovial fluid of osteoarthritic dogs.

Salinardi BJ, Roush JK, Schermerhorn T, Mitchell KE.

Vet Comp Orthop Traumatol. 2006;19(1):49-55.

PMID:
16594544
9.

Endogenous nitric oxide production in canine osteoarthritis: Detection in urine, serum, and synovial fluid specimens.

Spreng D, Sigrist N, Schweighauser A, Busato A, Schawalder P.

Vet Surg. 2001 Mar-Apr;30(2):191-9.

PMID:
11230774
10.

Nitric oxide metabolite production in the cranial cruciate ligament, synovial membrane, and articular cartilage of dogs with cranial cruciate ligament rupture.

Spreng D, Sigrist N, Jungi T, Busato A, Lang J, Pfister H, Schawalder P.

Am J Vet Res. 2000 May;61(5):530-6.

PMID:
10803648
11.
13.

The effects of doxycycline on nitric oxide and stromelysin production in dogs with cranial cruciate ligament rupture.

Jauernig S, Schweighauser A, Reist M, Von Rechenberg B, Schawalder P, Spreng D.

Vet Surg. 2001 Mar-Apr;30(2):132-9.

PMID:
11230767
14.

Measurement of serum C-reactive protein concentration for discriminating between suppurative arthritis and osteoarthritis in dogs.

Hillström A, Bylin J, Hagman R, Björhall K, Tvedten H, Königsson K, Fall T, Kjelgaard-Hansen M.

BMC Vet Res. 2016 Oct 28;12(1):240.

15.

The potential and limitations of cartilage-specific (V+C)(-) fibronectin and cartilage oligomeric matrix protein as osteoarthritis biomarkers in canine synovial fluid.

Steffey MA, Miura N, Todhunter RJ, Nykamp SG, Freeman KP, Scarpino V, Vernier-Singer MA, Erb HN, MacLeod JN, Lust G, Burton-Wurster N.

Osteoarthritis Cartilage. 2004 Oct;12(10):818-25.

16.

MMP-2 as an early synovial biomarker for cranial cruciate ligament disease in dogs.

Boland L, Danger R, Cabon Q, Rabillard M, Brouard S, Bouvy B, Gauthier O.

Vet Comp Orthop Traumatol. 2014;27(3):210-5. doi: 10.3415/VCOT-13-06-0082. Epub 2014 Mar 25.

PMID:
24664192
19.

Use of biochemical markers of osteoarthritis to investigate the potential disease-modifying effect of tibial plateau levelling osteotomy.

Girling SL, Bell SC, Whitelock RG, Rayward RM, Thomson DG, Carter SC, Vaughan-Thomas A, Innes JF.

J Small Anim Pract. 2006 Dec;47(12):708-14.

PMID:
17201821
20.

Supplemental Content

Support Center